Middle East Medical Devices Market Size, Share & Trends Analysis Report By Product (In Vitro Diagnostics(IVD), Cardiology), By FDA Classification (Class I, Class II and Class III), By End-use, By Region, And Segment Forecast, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Middle East & Africa Parenteral Nutrition Market Growth & Trends
The Middle East & Africa parenteral nutrition market size is expected to reach USD 346.0 million by 2030, registering a CAGR of 4.4%, according to a new report by Grand View Research, Inc. The MEA parenteral nutrition market is expected to witness lucrative growth over the forecast period owing to various parameters such as presence of large pool of malnourished children, rising premature births, increasing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer within the region.
Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.
Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.
Middle East & Africa Parenteral Nutrition Market Report Highlights
Middle East & Africa Parenteral Nutrition Market Growth & Trends
The Middle East & Africa parenteral nutrition market size is expected to reach USD 346.0 million by 2030, registering a CAGR of 4.4%, according to a new report by Grand View Research, Inc. The MEA parenteral nutrition market is expected to witness lucrative growth over the forecast period owing to various parameters such as presence of large pool of malnourished children, rising premature births, increasing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer within the region.
Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.
Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.
Middle East & Africa Parenteral Nutrition Market Report Highlights
- Single dose amino acid solutions held a dominant share in 2023. This dominance is governed by the influx of innovative products. In addition, these innovative formulations are more efficient and cause lesser adverse effects.
- Intravenous lipid emulsions are anticipated to witness lucrative growth over the forecast period. Drug delivery through lipid emulsion is expected to showcase promising results as it results in minimal adverse effects such as irritation, pain, and thrombophlebitis.
- Adults dominated the market and accounted for 85.9% in 2023. The compromised gastrointestinal function, prolonged malnutrition, and increased malnutrition in adults drive the segmental growth.
- Cancer care dominated the market and accounted for a market share of 16.9% in 2023. It can be attributed to the rising cancer cases in the Middle East and African region.
- Institutional sales channels dominated the market and accounted for a market share of 49.2% in 2023. The large share of the segment can be attributed to the increasing allowance for the adoption of technologically advanced medical devices and parenteral nutrition solutions in settings such as hospitals and clinics.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST MEDICAL DEVICES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Middle East Medical Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. MIDDLE EAST MEDICAL DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Middle East Medical Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. In Vitro Diagnostics (IVD)
4.3.1. In Vitro Diagnostics (IVD) Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cardiology
4.4.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Orthopedics
4.5.1. Orthopedics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Diagnostic imaging
4.6.1. Diagnostic imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Ophthalmic
4.7.1. Ophthalmic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. General and plastic surgery
4.8.1. General and plastic surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Drug delivery
4.9.1. Drug delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Endoscopy
4.10.1. Endoscopy Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.11. Dental
4.11.1. Dental Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.12. Wound management
4.12.1. Wound management Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.13. Diabetic care
4.13.1. Diabetic care Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.14. Nephrology
4.14.1. Nephrology Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.15. Ear, Nose, and Throat
4.15.1. Ear, Nose, and Throat Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.16. General hospital and Healthcare
4.16.1. General hospital and Healthcare Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.17. Neurology
4.17.1. Neurology Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.18. Skin Care & Aesthetics
4.18.1. Skin Care & Aesthetics Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.19. Others
4.19.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. MIDDLE EAST MEDICAL DEVICES MARKET: FDA CLASSIFICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Middle East Medical Devices Market: FDA Classification Movement Analysis, 2023 & 2030 (USD Million)
5.3. Class I
5.3.1. Class I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Class II
5.4.1. Class II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Class III
5.5.1. Class III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. MIDDLE EAST MEDICAL DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Middle East Medical Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Clinics
6.4.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Laboratories
6.5.1. Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Blood Banks
6.6.1. Blood Banks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Pharmacies
6.7.1. Pharmacies Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Stand Alone Clinics
6.8.1. Stand Alone Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Dermatology Clinics & Cosmetic
6.9.1. Dermatology Clinics & Cosmetic Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Others
6.10.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. MIDDLE EAST MEDICAL DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Middle East Medical Devices Market Share, By Region, 2023 & 2030 (USD Million)
7.2. Middle East
7.2.1. Middle East Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. Saudi Arabia
7.2.2.1. Saudi Arabia Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. UAE
7.2.3.1. UAE Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Kuwait
7.2.4.1. Kuwait Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.5. Qatar
7.2.5.1. Qatar Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.6. Oman
7.2.6.1. Oman Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.7. Bahrain
7.2.7.1. Bahrain Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.8. Egypt
7.2.8.1. Egypt Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.9. Iran
7.2.9.1. Iran Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.10. Iraq
7.2.10.1. Iraq Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.11. Cyprus
7.2.11.1. Cyprus Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.12. Jordan
7.2.12.1. Jordan Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.13. Turkey
7.2.13.1. Turkey Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.14. Lebanon
7.2.14.1. Lebanon Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Medtronic
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Koninklijke Philips N.V.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. GE HealthCare
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Abbott
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Smith+Nephew
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. COLOPLAST
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Saudi Mais CO.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Zimmer Biomet
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Siemens
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Roche Diagnostics
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. BD
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. Olympus
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST MEDICAL DEVICES MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Middle East Medical Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. MIDDLE EAST MEDICAL DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Middle East Medical Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. In Vitro Diagnostics (IVD)
4.3.1. In Vitro Diagnostics (IVD) Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cardiology
4.4.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Orthopedics
4.5.1. Orthopedics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Diagnostic imaging
4.6.1. Diagnostic imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Ophthalmic
4.7.1. Ophthalmic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. General and plastic surgery
4.8.1. General and plastic surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Drug delivery
4.9.1. Drug delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Endoscopy
4.10.1. Endoscopy Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.11. Dental
4.11.1. Dental Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.12. Wound management
4.12.1. Wound management Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.13. Diabetic care
4.13.1. Diabetic care Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.14. Nephrology
4.14.1. Nephrology Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.15. Ear, Nose, and Throat
4.15.1. Ear, Nose, and Throat Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.16. General hospital and Healthcare
4.16.1. General hospital and Healthcare Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.17. Neurology
4.17.1. Neurology Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.18. Skin Care & Aesthetics
4.18.1. Skin Care & Aesthetics Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.19. Others
4.19.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. MIDDLE EAST MEDICAL DEVICES MARKET: FDA CLASSIFICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Middle East Medical Devices Market: FDA Classification Movement Analysis, 2023 & 2030 (USD Million)
5.3. Class I
5.3.1. Class I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Class II
5.4.1. Class II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Class III
5.5.1. Class III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. MIDDLE EAST MEDICAL DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Middle East Medical Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Clinics
6.4.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Laboratories
6.5.1. Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Blood Banks
6.6.1. Blood Banks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Pharmacies
6.7.1. Pharmacies Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Stand Alone Clinics
6.8.1. Stand Alone Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Dermatology Clinics & Cosmetic
6.9.1. Dermatology Clinics & Cosmetic Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Others
6.10.1. Others Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. MIDDLE EAST MEDICAL DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Middle East Medical Devices Market Share, By Region, 2023 & 2030 (USD Million)
7.2. Middle East
7.2.1. Middle East Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. Saudi Arabia
7.2.2.1. Saudi Arabia Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. UAE
7.2.3.1. UAE Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Kuwait
7.2.4.1. Kuwait Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.5. Qatar
7.2.5.1. Qatar Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.6. Oman
7.2.6.1. Oman Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.7. Bahrain
7.2.7.1. Bahrain Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.8. Egypt
7.2.8.1. Egypt Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.9. Iran
7.2.9.1. Iran Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.10. Iraq
7.2.10.1. Iraq Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.11. Cyprus
7.2.11.1. Cyprus Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.12. Jordan
7.2.12.1. Jordan Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.13. Turkey
7.2.13.1. Turkey Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.14. Lebanon
7.2.14.1. Lebanon Middle East Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Medtronic
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Koninklijke Philips N.V.
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. GE HealthCare
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Abbott
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Smith+Nephew
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. COLOPLAST
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Saudi Mais CO.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Zimmer Biomet
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Siemens
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Roche Diagnostics
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. BD
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. Olympus
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives
